Corneal Crosslinking: When You Need It and How It Protects Your Vision

Corneal crosslinking is a preventive and therapeutic procedure that strengthens the tissue of the cornea and stops it from thinning and bulging further. It is the cornerstone of keratoconus treatment, because it halts the progression of the condition and protects the patient from complications that can reach the point of vision loss.

How does crosslinking work?

The procedure combines riboflavin drops (vitamin B2) with a carefully measured dose of ultraviolet light, which creates new bonds between the collagen fibers inside the cornea. These bonds make the tissue stronger and better able to resist bulging, so the disease stops advancing.

Who is a candidate?

Crosslinking is usually recommended in the following cases:

• Patients with early or moderate keratoconus, especially when the condition is shown to be progressing.
• Teenagers and young adults, in whom the disease tends to be more active.
• People with weakened corneal tissue after certain vision correction procedures.

What happens after the procedure?

The procedure is short and done under anesthetic drops, and the patient goes home the same day. Some sensitivity and blurred vision in the first few days is normal, then vision settles gradually over a few weeks. The doctor prescribes lubricating drops and others that reduce inflammation during recovery. Most importantly, the goal of the procedure is to stop the decline and preserve the sight you have, not necessarily to improve vision dramatically.